Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis

Rheumatology International

Volumn 29, Issue 4, 2009, Pages 417-425

  Zhou, Yan Bin ^a   Ye, Ren Gao ^a   Li, You Ji ^a   Xie, Can Mao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anti CD134 mAb; Cytokines; Lupus nephritis; RhCD134; T helper cell balance

Indexed keywords

CD134 ANTIGEN; CD3 ANTIBODY; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD134; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LUPUS NEPHRITIS; MALE; OX40 LIGAND; RECEPTORS, OX40; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 59449106441     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0697-2     Document Type: Article

References (39)

1. AD Weinberg DE Evans C Thalhofer T Shi RA Prell 2004 The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement J Leukoc Biol 75 962 972 10.1189/jlb.1103586
2. TH Watts 2005 TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 23 23 68 10.1146/annurev.immunol.23.021704.115839
3. AD Weinberg 2002 OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines Trends Immunol 23 102 109 10.1016/S1471-4906(01)02127-5
4. Y Ohshima LP Yang T Uchiyama 1998 OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4+ T cells into high IL-4 producing effectors Blood 92 3338 3345
5. H Akiba Y Miyahira M Atsuta K Takeda C Nohara T Futagawa 2000 Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis J Exp Med 191 375 380 10.1084/jem.191.2.375
6. J Aten A Roos N Claessen EJ Schilder-Tol IJ Ten Berge JJ Weening 2000 Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis J Am Soc Nephrol 11 1426 1438
7. M Tucci N Calvani HB Richards C Quatraro F Silvestris 2005 The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis Ann N Y Acad Sci 1051 421 432 10.1196/annals.1361.084
8. M Arringer JS Smolen 2005 Cytokine expression in lupus kidneys Lupus 14 13 18 10.1191/0961203305lu2053oa
9. RW Chan FM Lai EK Li LS Tam KM Chow PK Li 2007 Intrarenal cytokine gene expression in lupus nephritis Ann Rheum Dis 66 886 892 10.1136/ard.2006.063123
10. H Nakashima M Akahoshi K Masutani 2006 Th1/Th2 balance of SLE patients with lupus nephritis Rinsho Byori 54 706 713
11. LM Higgins SA McDonald N Whittle 1999 Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein J Immunol 162 486 493
12. RH Arch CB Thompson 1998 4-1 BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB Mol Cell Biol 18 558 565
13. D Odobasic AR Kitching PG Tipping SR Holdsworth 2005 CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms Kidney Int 68 584 594 10.1111/j.1523-1755.2005.00436.x
14. S Patschan S Dolff A Kribben J Durig D Patschan B Wilde 2006 CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus Clin Exp Immunol 145 235 242 10.1111/j.1365-2249.2006.03141.x
15. Ye RG (2000) Systemic lupus erythematosus. In: Textbook of internal medicine. People's Publishing House of Public Health, Beijing City, pp 909-915
16. C Bombardier DD Gladman MB Urowitz D Caron CH Chang 1992 Derivation of the SLEDAI: a disease activity index for lupus patients. The committee on prognosis studies in SLE Arthritis Rheum 35 630 640 10.1002/art.1780350606
17. AE Chang A Aruga MJ Cameron VK Sondak DP Normolle BA Fox 1997 Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2 J Clin Oncol 15 796 807
18. H Huang H Yu SD Xiong 2001 Enhancement of anti-CD4 mAb on anti-tumor activity of tumor-specific T cells activated by rIL-2 and anti-CD3 mAb J Cell Mol Immunol 17 160 164
19. C Yi-wei BA Fox 2001 Induction of tumor-specific Th1 cell response in vitro by anti-OX-40 and anti-IL-4 Shanghai J Immunol 21 148 150 Chinese
20. YB Zhou YJ Li YH Wu 2006 Study on the levels in the serum and mRNA expression in PBMCs of interleukin-10 and interferon-γ of patients with lupus nephritis China J Mod Med 16 529 532 Chinese
21. MJ Pillet TR Mempel 2008 Regulation of T-cell migration and effector functions: insight in in vivo imaging studies Immunol Rev 221 107 129 10.1111/j.1600-065X.2008.00584.x
22. AD Weinberg C Thalhofer N Morris JM Walker D Seiss S Wong 1997 Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study J Immunother 29 575 585 10.1097/01.cji.0000211319.00031.fc
23. T Totsuka T Kanai K Uraushihara T Iiyama M Yamazaki H Akiba 2003 Therapeuetic effect of anti-OS40L and anti-TNF-alpha MAbs in a murine model of chronic colitis Am J Physiol Gastrointest Liver Physiol 284 G595 G603
24. X Yuan AD Salama V Dong I Schmitt N Najafian A Chandraker 2003 The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo J Immunol 170 2949 2955
25. BR Blazar AH Sharpe AI Chen A Panoskaltsis-Mortari C Lees H Akiba H Yagita N Killeen PA Taylor 2003 Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients Blood 101 3741 3748
26. T Yoshioka A Nakajima H Akiba T Ishiwata G Asano S Yoshino 2000 Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis Eur J Immunol 30 2815 2823 10.1002/1521-4141(200010)30:10<2815:: AID-IMMU2815>3.0.CO;2-#
27. L Taylor M Bachler I Duncan S Keen R Fallon C Mair 2002 In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions J Leukoc Biol 72 522 529
28. AJ Curry J Chikwe XG Smith M Cai H Schwarz JA Bradley 2004 OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival Transplantation 78 807 814 10.1097/01.TP.0000131670.99000.54
29. J Kjaergaard LX Wang H Kuriyama S Shu GE Plautz 2005 Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines J Neurosurg 103 156 164
30. NP Morris C Peters R Montler HM Hu BD Curti WJ Urba 2007 Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain Mol Immunol 44 3112 3121 10.1016/j.molimm.2007. 02.004
31. I Gramaglia AD Weinberg M Lemon 1998 OX-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell reponses J Immunol 161 6510 6517
32. AD Weinberg MM Rivera RJ Prell 2000 Engagement of the OX-40 receptor in vivo enhances antitumor immunity J Immunol 164 2160 2169
33. PR Rogers J Song I Gramaglia 2001 OX40 promotes Bcl-XL and Bcl-2 expression and is essential for long-term survival of CD4 T cells Immunity 15 445 455 10.1016/S1074-7613(01)00191-1
34. JR Maxwell A Weinberg RA Prell 2000 Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inbibiting peripheral deletion J Immunol 164 107 112
35. M Li Y Zhang 2006 Effect of antibody to CD134 on perforin-mediated cytolysis in human peripheral blood mononuclear cells Hybridoma 25 145 153 10.1089/hyb.2006.25.145
36. I Takeda S Ine N Killeen 2004 Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells J Immunol 172 3580 3589
37. SK Agarwal GD Marshall Jr 2001 Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines J Interferon Cytokine Res 21 147 155 10.1089/107999001750133159
38. M Amit A Mor J Weissgarten R Rosenberg Y Ramot AJ Wysenbeek 2000 Inactive systemic lupus erythematosus is associated with a normal stimulated Th(1)/Th(2) cytokine secretory pattern Cytokine 12 1405 1408 10.1006/cyto.2000.0724
39. M Akahoshi H Nakashima Y Tanaka T Kohsaka S Nagano E Ohgami 1999 Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus Arthritis Rheum 42 1644 1648 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2- L